Candida-associated gastric ulcer occurs not only in debilitated but healthy individuals. Though had been reported to demonstrate nothing but nonspecific endoscopic features, it occasionally exhibits a typical finding I designated a candidarium. The natural history of the disease had not been clarified and the recurrence had not been described: the fungus had been reported to become undetectable once the ulcers were healed.
However, I demonstrated that the ulcer not only occurs but also recurs in a different site with a different shape in a non-diabetic, Helicobacter pylori (H. pylori)-negative patient, who has not been given non- steroidal anti- inflammatory drugs, antibiotics, antineoplastic agents, or systemic corticosteroids, advocating that, contrary to the prevailing opinion, Candida is no innocuous bystander but an etiologic perpetrator: intragastric inoculation of C. albicans causes epithelial necrosis through activation of IL- 23/IL-17 pathway in mice. In the oropharyngeal field, the fungus has recently been shown to secrete a cytolytic pore-forming toxin (PFT), candidalysin, into a pocket in the epithelium after penetrating into it to activate mitogen-activated protein kinase (MAPK)/MAPK phosphatase 1 (MKP1)/c-Fos pathway, triggering release of damage as well as immune cytokines. Similar phenomenon is also observed in vulvovaginal candidiasis (VVC). While candidalysin, exerting an effect even on the adjacent oropharyngeal cells, directly injures the tissue with damage cytokines, immune counterparts activate polymorphonuclear leukocytes to eventually terminate inflammation. Though the epithelial response to the fungus is different from organ to organ, it invades into and induces necrotic cellular damage to the intestinal mucosa through the toxin to translocate: the action of candidalysin is proven not only on the stratified squamous mucosa but on the single layer of the columnar epithelium. Since, by analogy with intestinal candidiasis, it is never difficult to speculate that the PFT inflicts such damage to the gastric mucosa, a theoretically strong possibility has come up that Candida-associated gastric ulcer is actually Candida-induced ulcer.
Kenji Sasaki received his MD in 1973 and PhD in 1977 from Tohoku University. He is a Board Certified Fellow and Preceptor of the Japan Gastroenterological Endoscopy Society, Board Certified Gastroenterologist of the Japanese Society of Gastroenterology, Board Certified Member of the Japanese Society of Internal Medicine and Editorial Board Member of CRIM. He has given presentations at international medical congresses and published papers on gastroenterology in international journals.
Acclaimed by Prof Tarnawski at DDW 2012, he published his article “Candida-associated gastric ulcer relapsing in a different position in a different appearance.” in World J Gastroenterol 2012 Aug 28; 18 (32): 4450-4453, which was featured in the section of Infection and Immunity of World Biomedical Frontiers in September, 2013 and recommended by an associate research scientist on PubAdvanced in December, 2013. Invited to participate in a special issue titled “Candidiasis – Causes, Symptoms, Treatment, Diagnosis” by Gynecol Reprod Med, he published a review article, an extended version of the above article titled “Candida-associated gastric ulcer until yesterday, today, and from tomorrow — In
quest of the etiology” in SciTz Gynecol Reprod Med 2017; 1(1): 1002. He served as a reviewer for CRIM, JMM, JPP and J Gastrointest Dig Syst.